Author | Michele Cavo, MD | OncLive

Author | Michele Cavo, MD

Articles

Dr. Michele Cavo on ASCT Role in Novel-Agent Era of Multiple Myeloma

August 12, 2016

Video

Michele Cavo, MD, professor, Seràgnoli Institute of Hematology, Bologna University School of Medicine, discusses the role of upfront autologous stem cell transplantation (ASCT) in multiple myeloma.

Dr. Cavo on Upfront ASCT in Multiple Myeloma

June 05, 2016

Video

Michele Cavo, MD, professor, Seràgnoli Institute of Hematology Bologna University School of Medicine, discusses the results of the phase III EMN02/HO95 MM trial, which compared the efficacy of upfront autologous stem cell transplantation versus novel agent-based therapy for the treatment of patients with multiple myeloma.

x